LIF Antibody

ArtNr	CSB-PA012928ESR2HU-50ul
Hersteller	Cusabio
Menge	50 ul
Quantity options	100 ul 50 ul
Kategorie	Oncology Metabolism Diabetes Glucose Homeostasis Antibodies Obesity Western Blot ELISA Primary Antibodies By Organ Skin Cancer Heart & Blood Cancer Immunostaining
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Konjugat/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	CDF antibody,Cholinergic Differentiation Factor antibody,D factor antibody,DIA antibody,Differentiation inducing factor antibody,differentiation inhibitory activity antibody,Differentiation stimulating factor antibody,Differentiation-stimulating factor antibody,Emfilermin antibody,Hepatocyte stimulating factor III antibody,HILDA antibody,Human interleukin in DA cells antibody,Leukemia inhibitory factor antibody,LIF antibody,LIF_HUMAN antibody,Melanoma derived LPL inhibitor antibody,Melanoma-derived LPL inhibitor antibody,MLPLI antibody
Similar products	LIF, HILDA, Leukemia inhibitory factor (LIF) (Differentiation-stimulating factor) (D factor) (Melanoma-derived LPL inhibitor) (MLPLI) (Emfilermin)
Lieferbar
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Targets	LIF
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	CDF antibody, Cholinergic Differentiation Factor antibody, D factor antibody, DIA antibody, Differentiation inducing factor antibody, differentiation inhibitory activity antibody, Differentiation stimulating factor antibody, Differentiation-stimulating factor antibody, Emfilermin antibody, Hepatocyte stimulating factor III antibody, HILDA antibody, Human interleukin in DA cells antibody, Leukemia inhibitory factor antibody, LIF antibody, LIF_HUMAN antibody, Melanoma derived LPL inhibitor antibody, Melanoma-derived LPL inhibitor antibody, MLPLI antibody
Immunogen Species	Human
Immunogen	Recombinant Human Leukemia inhibitory factor protein (23-202AA)
Background	LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
Buffer	PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification Method	Antigen Affinity Purified
General Research Areas	Immunology
Initial Research Areas	Immunology
Antigen Species	Human
Antigen	Recombinant Human Leukemia inhibitory factor protein (23-202AA)
Clonality	Polyclonal

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

CSB-PA012928ESR2HU-50ul-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 50 ul

lieferbar

Lieferung vsl. bis 18.12.2025